Chris Rallis, Director at Fennec Pharmaceuticals, holds 45.84K shares in Fennec Pharmaceuticals (Ticker: FENC), holds ― shares in Tenax Therapeutics (Ticker: TENX). Most recently, Chris Rallis Sold ― shares of Fennec Pharmaceuticals on Apr 15, 2024 for an estimated value of 8.36K.